MA33004B1 - Synthese de styrylpyridines radiomarquees au 18f a partir de precurseurs de tosylate et leurs compositions pharmaceutiques stables - Google Patents

Synthese de styrylpyridines radiomarquees au 18f a partir de precurseurs de tosylate et leurs compositions pharmaceutiques stables

Info

Publication number
MA33004B1
MA33004B1 MA34065A MA34065A MA33004B1 MA 33004 B1 MA33004 B1 MA 33004B1 MA 34065 A MA34065 A MA 34065A MA 34065 A MA34065 A MA 34065A MA 33004 B1 MA33004 B1 MA 33004B1
Authority
MA
Morocco
Prior art keywords
styrylperidine
beryllium
synthesis
indicated
pharmacological compositions
Prior art date
Application number
MA34065A
Other languages
Arabic (ar)
English (en)
French (fr)
Inventor
Tyler Benedum
Geoff Golding
Nathaniel Lim
Wei Zhang
Original Assignee
Avid Radiopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avid Radiopharmaceuticals Inc filed Critical Avid Radiopharmaceuticals Inc
Publication of MA33004B1 publication Critical patent/MA33004B1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0069Devices for implanting pellets, e.g. markers or solid medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Optics & Photonics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Dermatology (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA34065A 2008-12-31 2009-12-29 Synthese de styrylpyridines radiomarquees au 18f a partir de precurseurs de tosylate et leurs compositions pharmaceutiques stables MA33004B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14188508P 2008-12-31 2008-12-31
PCT/US2009/069741 WO2010078370A1 (en) 2008-12-31 2009-12-29 Synthesis of 18f-radiolabeled styrylpyridines from tosylate precursors and stable pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
MA33004B1 true MA33004B1 (fr) 2012-01-02

Family

ID=42310197

Family Applications (1)

Application Number Title Priority Date Filing Date
MA34065A MA33004B1 (fr) 2008-12-31 2009-12-29 Synthese de styrylpyridines radiomarquees au 18f a partir de precurseurs de tosylate et leurs compositions pharmaceutiques stables

Country Status (35)

Country Link
US (1) US20100172836A1 (enExample)
EP (1) EP2381967B1 (enExample)
JP (1) JP5717650B2 (enExample)
KR (1) KR20110119670A (enExample)
CN (1) CN102271716B (enExample)
AU (1) AU2009335049B2 (enExample)
BR (1) BRPI0923890A2 (enExample)
CA (1) CA2748705C (enExample)
CO (1) CO6341578A2 (enExample)
CR (1) CR20110410A (enExample)
CY (1) CY1118658T1 (enExample)
DK (1) DK2381967T3 (enExample)
DO (1) DOP2011000210A (enExample)
EA (1) EA023014B1 (enExample)
EC (1) ECSP11011242A (enExample)
ES (1) ES2620402T3 (enExample)
HN (1) HN2011001810A (enExample)
HR (1) HRP20170453T1 (enExample)
HU (1) HUE033649T2 (enExample)
IL (1) IL213674A (enExample)
LT (1) LT2381967T (enExample)
MA (1) MA33004B1 (enExample)
MX (1) MX2011007063A (enExample)
MY (1) MY162312A (enExample)
NZ (1) NZ593848A (enExample)
PE (1) PE20120007A1 (enExample)
PL (1) PL2381967T3 (enExample)
PT (1) PT2381967T (enExample)
RS (1) RS55674B1 (enExample)
SG (1) SG172439A1 (enExample)
SI (1) SI2381967T1 (enExample)
TN (1) TN2011000318A1 (enExample)
UA (1) UA105914C2 (enExample)
WO (1) WO2010078370A1 (enExample)
ZA (1) ZA201104824B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010039815A1 (en) * 2008-09-30 2010-04-08 Case Western Reserve University Molecular probes for imaging of myelin
SG185785A1 (en) 2010-06-04 2013-01-30 Piramal Imaging Sa Method for production of f-18 labeled amyloid beta ligand
TWI504414B (zh) 2010-06-04 2015-10-21 Bayer Schering Pharma Ag 生產F-18標記之Aβ配位體之方法
CA2801530C (en) 2010-06-04 2017-09-12 Piramal Imaging Sa Method for production of f-18 labeled amyloid beta ligands
EP2699157B1 (en) 2011-04-21 2018-03-14 The Regents of The University of California Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles
EP2723394B1 (en) * 2011-06-21 2018-05-23 Piramal Imaging SA Formulations of fluorinated stilbene suitable for pet imaging
EP2768790A1 (en) 2011-10-19 2014-08-27 Piramal Imaging SA IMPROVED METHOD FOR PRODUCTION OF F-18 LABELED Aß LIGANDS
CN102432529B (zh) * 2011-11-14 2014-03-26 江苏省原子医学研究所 一种苯乙烯基吡啶二硫二氮衍生物的制备方法
EP2791113A1 (en) * 2011-12-15 2014-10-22 GE Healthcare UK Limited Heterocyclic compounds as imaging probes of tau pathology
CN102526765B (zh) * 2011-12-31 2014-07-30 郑州泰基鸿诺药物科技有限公司 一种Aβ斑块显像剂及其制备方法
CN103965105A (zh) * 2013-01-29 2014-08-06 中山大学 苯乙烯基喹啉衍生物及其在治疗阿尔茨海默病症中的应用
CN103645254B (zh) * 2013-11-28 2015-01-07 江苏省原子医学研究所 一种Aβ斑块显像剂前体AV45的含量分析方法
WO2017014599A1 (ko) * 2015-07-22 2017-01-26 주식회사 씨코헬스케어 [18f]플루오로-도파의 방사화학적 순도를 안정화시키는 조성물 및 이의 제조방법
US10301308B2 (en) * 2015-11-13 2019-05-28 Eli Lilly And Company Azetidine derivatives for tau imaging
EP3426309B1 (en) * 2016-03-09 2022-05-04 Case Western Reserve University Radioligands for myelin
CN107198780A (zh) * 2016-03-18 2017-09-26 南京江原安迪科正电子研究发展有限公司 放射性药物组合物及其制备方法、应用
CN106018575B (zh) * 2016-05-05 2018-10-19 江苏省原子医学研究所 一种PET显像剂前体TsOP-(+)-DTBZ及其光学异构体的分离测定方法
US10695450B2 (en) * 2016-07-26 2020-06-30 Laboratoires Cyclopharma Synthesis of a radioactive agent composition
US10377701B2 (en) * 2016-11-08 2019-08-13 The Regents Of The University Of California Methods for multi-dose synthesis of [F-18]FDDNP for clinical settings
TW201906818A (zh) * 2017-05-31 2019-02-16 美商511製藥公司 新穎氘取代之正子發射斷層掃描(pet)顯影劑及其藥理應用
JP7260552B2 (ja) * 2018-01-24 2023-04-18 エーシー・イミューン・エス・アー Pet画像化のための診断用組成物、診断用組成物を製造するための方法及び診断におけるその使用
CN111499544B (zh) * 2019-01-31 2022-12-02 中国医学科学院放射医学研究所 一种一锅法制备N-Boc-N-甲基-4-氨基苯乙烯的合成方法
CN111499570B (zh) * 2019-01-31 2023-05-16 中国医学科学院放射医学研究所 一种av-45中间体的合成方法
US20220175973A1 (en) * 2019-03-29 2022-06-09 National Institutes for Quantum Science and Technology Method for producing radiopharmaceutical and radiopharmaceutical
CN115400232A (zh) * 2021-05-26 2022-11-29 汉中汉核医疗科技有限公司 一种放射性药物合成方法
CN115403434A (zh) * 2021-05-26 2022-11-29 汉中汉核医疗科技有限公司 一种放射性药物的合成方法
CN113582885B (zh) * 2021-08-30 2023-04-21 南京克米斯璀新能源科技有限公司 一种烷基磺酸钠的生产方法
CN114805190A (zh) * 2022-06-08 2022-07-29 吉林大学第一医院 一种甲基苯胺类Aβ蛋白显像剂的双柱合成方法
CN120187703A (zh) * 2022-11-14 2025-06-20 伊莱利利公司 氟贝他吡前体av-105的多晶型物
CN119080714A (zh) * 2024-09-12 2024-12-06 四川大学 一种偶氮苯磺酸酯化合物及其制备方法和应用、放射性探针的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007525211A (ja) * 2004-01-19 2007-09-06 テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド パーキンソン病の診断検査
NZ555942A (en) * 2004-12-17 2011-01-28 Univ Pennsylvania Radiolabelled tilbene derivatives and their use for binding and imaging amyloid plaques
ES2628882T3 (es) * 2006-03-30 2017-08-04 The Trustees Of The University Of Pennsylvania Derivados de estirilpiridina, y su uso para unir y formar imágenes de placas amiloides

Also Published As

Publication number Publication date
CO6341578A2 (es) 2011-11-21
CY1118658T1 (el) 2017-07-12
ECSP11011242A (es) 2011-10-31
CA2748705C (en) 2017-05-02
DK2381967T3 (en) 2017-03-27
CA2748705A1 (en) 2010-07-08
UA105914C2 (uk) 2014-07-10
EP2381967B1 (en) 2017-01-18
EP2381967A4 (en) 2013-01-02
MX2011007063A (es) 2011-12-16
SG172439A1 (en) 2011-07-28
MY162312A (en) 2017-05-31
PT2381967T (pt) 2017-02-24
ES2620402T3 (es) 2017-06-28
IL213674A (en) 2016-04-21
AU2009335049B2 (en) 2015-07-16
AU2009335049A1 (en) 2011-07-21
SI2381967T1 (sl) 2017-03-31
HK1162951A1 (en) 2012-09-07
CN102271716B (zh) 2014-11-19
US20100172836A1 (en) 2010-07-08
PE20120007A1 (es) 2012-01-16
RS55674B1 (sr) 2017-06-30
TN2011000318A1 (en) 2012-12-17
HRP20170453T1 (hr) 2017-06-02
JP2012514007A (ja) 2012-06-21
ZA201104824B (en) 2013-01-30
BRPI0923890A2 (pt) 2015-07-28
PL2381967T3 (pl) 2017-06-30
CN102271716A (zh) 2011-12-07
HN2011001810A (es) 2013-08-12
EA201170911A1 (ru) 2011-12-30
KR20110119670A (ko) 2011-11-02
DOP2011000210A (es) 2011-09-15
HUE033649T2 (en) 2017-12-28
WO2010078370A1 (en) 2010-07-08
IL213674A0 (en) 2011-07-31
CR20110410A (es) 2011-12-08
NZ593848A (en) 2013-09-27
EA023014B1 (ru) 2016-04-29
JP5717650B2 (ja) 2015-05-13
LT2381967T (lt) 2017-04-25
EP2381967A1 (en) 2011-11-02

Similar Documents

Publication Publication Date Title
EA201170911A1 (ru) Синтез стирилпиридинов, меченных радиоактивным изотопомf, из предшественников тозилата и их стабильные фармацевтические композиции
JOP20180103A1 (ar) مركب صيدلاني
UY31367A1 (es) Derivados de nicotinamida, su preparacion y su aplicacion en terapeutica
EA201001683A1 (ru) Производные фенил- или пиридинилзамещенных индазолов
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
HK1203309A1 (zh) 抗體-藥物綴合物以及相關化合物、組合物和方法
MX2011011797A (es) Fenilureas y fenilamidas sustituidas como ligandos del receptor de vanilloides.
EA201290183A1 (ru) Бензодиазепиновый ингибитор бромодомена
MX353706B (es) Anticuerpos contra csf-1r humano y usos de los mismos.
EA201291143A1 (ru) Пиразолилхиназолиновые ингибиторы киназы
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
EA201190297A1 (ru) Инъецируемые композиции мелфалана, содержащие производное циклодекстрина, и способы их получения и применения
EA201000113A1 (ru) Пиразольные соединения
EA201390381A1 (ru) Триазиноксадиазолы
EP2590649A4 (en) PROCESS FOR SYNTHESIS OF SUBSTITUTED MORPHINANES
UA107455C2 (uk) Похідні індолу як протиракові агенти
UY32517A (es) Derivados de nicotinamida, su preparación y su aplicación en terapéutica
CY1112829T1 (el) Νεα μεθοδος συνθεσης για την αγομελατινη
MX2010009860A (es) Sintesis total de salinosporamida a y sus analogos.
EA201000703A1 (ru) Производные пиразола в качестве ингибиторов 5-lo
EA201390336A1 (ru) Способ получения промежуточного соединения для синтеза лекарственного средства
EA201200820A1 (ru) Способ синтеза промежуточных продуктов, применимых для получения замещенных индазолов и азаиндазолов
UY31972A (es) Derivados anticancerosos, su preparación y su aplicación en terapéutica
DE602007005387D1 (de) Ptors
NZ598659A (en) Automated radiosynthesis